Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 27, 2026 13:30 ET | Source: ABO - Group

ABO-Group Environment – Results Second half-year 2025 and full year 2025

Ghent, 27 March 2026 – 18:30 – Press release / regulated information – inside information ABO-Group Environment achieves its revenue target with double-digit growth in 2025. Highlights 2025 With...
March 27, 2026 13:11 ET | Source: Law Offices of Howard G. Smith

DEADLINE ALERT for MNDY, CWH, TCOM, ODD: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions

BENSALEM, Pa., March 27, 2026 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
March 27, 2026 13:00 ET | Source: Monopar Therapeutics Inc.

Monopar Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Business Update

WILMETTE, Ill., March 27, 2026 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar,” the “Company,” “we”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company developing innovative...
March 27, 2026 12:07 ET | Source: The Law Offices of Frank R. Cruz

DEADLINE ALERT for DRVN, MNDY, CWH, and TCOM: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

LOS ANGELES, March 27, 2026 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
March 27, 2026 12:00 ET | Source: LB Pharmaceuticals Inc

LB Pharmaceuticals Presents New Analysis from the Phase 2 NOVA-1 Trial Highlighting LB-102’s Potential Impact on Cognitive Performance at the 2026 Annual Congress of the Schizophrenia International Research Society (SIRS)

NEW YORK, March 27, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a late-stage biopharmaceutical company developing novel therapies for...
March 27, 2026 11:15 ET | Source: Research and Markets

Bispecific T-Cell Engagers Market Insights Report (2026-2030) Featuring Strategic Analysis of Pfizer, Johnson & Johnson, Roche, AbbVie, Sanofi and Other Key Players

Dublin, March 27, 2026 (GLOBE NEWSWIRE) -- The "Bispecific T-Cell Engagers Market Report 2026" has been added to ResearchAndMarkets.com's offering. The bispecific T-cell engagers market is...
March 27, 2026 11:13 ET | Source: Hagens Berman Sobol Shapiro LLP

Coty Inc. (COTY) Faces Securities Class Action Amid Surprise YoY Deterioration in Operating Income, CEO Departure, Withdrawn Guidance -- Hagens Berman

Investors who lost money in COTY after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
March 27, 2026 11:03 ET | Source: Research and Markets

Australia's mRNA Therapeutics Market Set to Expand at 19% CAGR Through 2035, Reaching USD 1.78 Billion

Dublin, March 27, 2026 (GLOBE NEWSWIRE) -- The "Australia mRNA Therapeutics Market: Industry Trends and Global Forecasts, till 2035 - Distribution by Application Area (COVID-19 and Other...
March 27, 2026 11:00 ET | Source: Umicore

Notice of ordinary and extraordinary shareholders’ meetings and publication of the Annual Report 2025

Notice of ordinary and extraordinary shareholders’ meetings Umicore invites its shareholders to participate in the ordinary and extraordinary shareholders’ meetings, which will be held on Thursday,...
March 27, 2026 10:56 ET | Source: The Gross Law Firm

MNDY Shareholder Alert: May 11, 2026 Lead Plaintiff Deadline in monday.com Ltd. Securities Class Action Lawsuit — The Gross Law Firm

NEW YORK, March 27, 2026 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of monday.com Ltd. (NASDAQ: MNDY). Shareholders who purchased shares of MNDY during the...